Beyond biologics: Amgen bets new drugs will pay dividend
Amgen executives believe the biotech giant will grow substantially in the next decade, pursuing drugs that treat major melanoma and bone loss.
Strength in numbers: Thousand Oaks firm taps crowds
Invested.in helps individuals and organizations tap their social networks for funding.
Teledyne regroups in face of defense cuts
Thousand Oaks-based Teledyne Technologies, a $1.6 billion military-industrial conglomerate, is rearranging itself to bolster its commercial camera sensor lines and shift toward the defense spending that’s farthest from the chopping block.
Cal Oaks merger closes
Encino-based California United Bank completed its $17.2 million acquisition of Thousand Oaks-based California Oaks State Bank on Dec. 31. Cal Oaks shareholders will receive compensation of $11.35 per share, half in cash and half in shares of California United common stock, the banks announced Jan. 3.
Orfalea sues cousin and development partner
Paul Orfalea, the founder of Kinko’s and a major presence on the South Coast business and philanthropic scenes, is suing his cousin over $27.8 million in allegedly unpaid loans to a development company the two co-founded. Orfalea and cousin Gary Safady founded Beverly Hills-based O&S Holdings in 1992. Its projects in the Tri-Counties include Zodo’s Bowling Read More →
Teledyne sells small-aircraft engine division for $186M
Teledyne is selling its small-aircraft engine business for $186 million to a Chinese company.
Amgen reports earnings drop
Thousand Oaks-based Amgen said Oct. 25 that third-quarter earnings fell 14 percent to $1.3 billion as revenue flatlined. Amgen is the world’s biggest biotech company and the largest private employer in the Tri-Counties. It reported adjusted earnings per share of $1.36, a decrease of 9 percent compared to the same quarter last year. Total revenue Read More →
